MARC-PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of MARC-PHARMA is 2.9% (moderate). The 2025 annual accounts show equity of €21,193 and a net result of €16,193. Its solvency ranks better than 72% of 22,536 sector peers (NACE 47, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
Identification
Legal formPrivate limited company
Founded26-12-2024
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
E-invoicing
Reachable via Peppol
Peppol ID
0208:1017943140
Registered
21-10-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 24 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Walcourt · 1 establishment unit since 2024
Ground area
5,204 m²
Building footprint
534 m²
Parcel 93076D0036/00F000, Wallonia. Linked by address, not a title deed.
1 establishment unit
MARC-PHARMA
since 2024unit no. 2.368.960.526
1 parcel
Wallonia
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 93076D0036/00F000 | Wallonia | 5,204 m² | 1 · 534 m² | - |
How the parcels are linked
Good to know
The parcel matches the address exactly.